2-Pyridyl P1′-Substituted Symmetry-Based Human Immunodeficiency Virus Protease Inhibitors (A-792611 and A-790742) with Potential for Convenient Dosing and Reduced Side Effects†
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2009 |
|---|---|
| Erschienen: |
2009 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
|---|---|
| Enthalten in: |
Journal of medicinal chemistry - 52(2009), 8, Seite 2571-2586 |
| Beteiligte Personen: |
Degoey, David A. [VerfasserIn] |
|---|
| BKL: |
|---|
| Umfang: |
16 |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
OLC1813904650 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC1813904650 | ||
| 003 | DE-627 | ||
| 005 | 20230515171557.0 | ||
| 007 | tu | ||
| 008 | 090420s2009 xx ||||| 00| ||und c | ||
| 028 | 5 | 2 | |a sw090420 |
| 035 | |a (DE-627)OLC1813904650 | ||
| 035 | |a (DE-599)GBVOLC1813904650 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 082 | 0 | 4 | |a 540 |a 610 |
| 084 | |a PHARM |2 fid | ||
| 084 | |a 44.42 |2 bkl | ||
| 100 | 1 | |a Degoey, David A. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a 2-Pyridyl P1′-Substituted Symmetry-Based Human Immunodeficiency Virus Protease Inhibitors (A-792611 and A-790742) with Potential for Convenient Dosing and Reduced Side Effects† |
| 264 | 1 | |c 2009 | |
| 300 | |a 16 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Grampovnik, David J. |4 oth | |
| 700 | 1 | |a Flentge, Charles A. |4 oth | |
| 700 | 1 | |a Flosi, William J. |4 oth | |
| 700 | 1 | |a Chen, Hui-ju |4 oth | |
| 700 | 1 | |a Yeung, Clinton M. |4 oth | |
| 700 | 1 | |a Randolph, John T. |4 oth | |
| 700 | 1 | |a Klein, Larry L. |4 oth | |
| 700 | 1 | |a Dekhtyar, Tatyana |4 oth | |
| 700 | 1 | |a Colletti, Lynn |4 oth | |
| 700 | 1 | |a Marsh, Kennan C. |4 oth | |
| 700 | 1 | |a Stoll, Vincent |4 oth | |
| 700 | 1 | |a Mamo, Mulugeta |4 oth | |
| 700 | 1 | |a Morfitt, David C. |4 oth | |
| 700 | 1 | |a Nguyen, Bach |4 oth | |
| 700 | 1 | |a Schmidt, James M. |4 oth | |
| 700 | 1 | |a Swanson, Sue J. |4 oth | |
| 700 | 1 | |a Mo, Hongmei |4 oth | |
| 700 | 1 | |a Kati, Warren M. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of medicinal chemistry |d Easton, Pa. : American Chemical Society, 1963 |g 52(2009), 8, Seite 2571-2586 |w (DE-627)129545201 |w (DE-600)218133-2 |w (DE-576)014995336 |x 0022-2623 |7 nnns |
| 773 | 1 | 8 | |g volume:52 |g year:2009 |g number:8 |g pages:2571-2586 |g extent:16 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-CHE | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_22 | ||
| 912 | |a GBV_ILN_24 | ||
| 912 | |a GBV_ILN_69 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_2005 | ||
| 912 | |a GBV_ILN_2221 | ||
| 912 | |a GBV_ILN_4012 | ||
| 912 | |a GBV_ILN_4125 | ||
| 912 | |a GBV_ILN_4219 | ||
| 912 | |a GBV_ILN_4305 | ||
| 912 | |a GBV_ILN_4309 | ||
| 936 | b | k | |a 44.42 |q AVZ |
| 951 | |a AR | ||
| 952 | |d 52 |j 2009 |e 8 |h 2571-2586 |g 16 | ||